News | October 19, 2011

ECG Screenings in Young Adults Identifies Potential Risk of Sudden Cardiac Death

October 19, 2011 – A new study proves the importance of electrocardiographic (ECG) screenings to identify heart abnormalities in young adults, including both athletes and non-athletes.  The study, published in the October edition of HeartRhythm, the official journal of the Heart Rhythm Society, demonstrates the success of a high-volume ECG screening program designed to identify potential life-threatening heart arrhythmias in high school students.  Of the more than 32,000 students screened, ECG abnormalities that may be associated with the risk of sudden cardiac death (SCD) were identified in more than 800 students.

More than 250,000 deaths occur each year as a result of sudden cardiac arrest (SCA) and, more specifically, SCD occurs in an estimated 2,000 young adults annually in the United States.[1]  While SCA among young adults is a serious concern, the primary challenge with ECG screenings on a large scale is the lack of efficiency and the likelihood for a large number of false positive results.  The study, led by Joseph Marek, M.D., of the Midwest Heart Foundation, used a standardized and community-based screening program following strict quality controls and performed an average of 880 ECG screenings each day.

The screenings were performed during regular school hours in twenty-four Chicago suburban high schools between September 2006 and May 2009.  In order to complete the study on a large scale, community volunteers participated in a successful and controlled training program. With the aid of the trained community volunteers, 32,561 students between the ages of 14 to 19, including athletes and non-athletes, were successfully screened. 

Results showed that 817 (2.5 percent) of the 32,561 screened had ECG abnormities that could be associated with SCD.  Specifically, left ventricular hypertrophy (LVH) was found in 141 participants, which may be associated with hypertrophic cardiomyopathy (HCM), the most common cause of SCD.  In addition, 100 participants were found with Prolonged QTc that may indicate Long QT syndrome, which may also be associated with SCD.

“The screening process is an important step in trying to save lives because it helps us identify the individuals who are at the greatest risk of SCA and, ultimately, it has the potential to prevent incidents of sudden death from occurring,” said Marek. “As proof, some European countries have implemented successful screening programs in high volume that show great success in reducing SCA in young adults.”

In a study conducted in Italy over a 26-year period [2], ECG screenings in young athletes demonstrated an 89 percent reduction in SCD.  It was proven that the incidence of sudden cardiac death in young competitive athletes substantially declined in the region of Italy where a nationwide systematic screening was introduced.  Studies like this show that it is important to understand the preventative and implementable measures that can be taken to decrease the death rate of young adults from SCA.

“We believe our findings demonstrate the feasibility of performing high-quality, low cost ECG screenings in large U.S. populations which creates the potential to reduce the overall rate of SCD in our country,” said Marek.

For more information: www.heartrhythmjournal.com

1. Atkins, Dianne et al. "Epidemiology and Outcomes From Out-of-Hospital Cardiac Arrest in Children." Circulation. 2009 March 9; 119: 1484-1491.

2. Corrado, Domenico et al. "Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticpation Screening Program." JAMA. 2006: 296 (13):1593-1601.

 

 

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Overlay Init